ANTI-DIABETES DRUG METFORMIN RECALLED OVER DOUBTS OF CONTAINING CANCER-CAUSING COMPOUND

Highlights

• The USFDA has previously released an alert in the month of May, where it had stated agency laboratory testing of several lots of extended-release (ER) metformin revealed levels of N-Nitrosodimethylamine (NDMA) above prescribed limit

• Metformin, a drug u...

9.71 BOTTLES OF METFORMIN HYDROCHLORIDE IN U.S. RECALLED BY LUPIN, GRANULES INDIA

Pharmaceutical companies Lupin and Granules India are presently recalling nearly 9.71 lakh bottles of generic diabetes drug in the United States in wake of the possibility of the affected lot contains cancer inducing nitrosodimethylamine (NDMA) above the acceptable intake limit. 
Acco...